chrX-142203273-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016249.4(MAGEC2):āc.715A>Gā(p.Ile239Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,209,261 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEC2 | NM_016249.4 | c.715A>G | p.Ile239Val | missense_variant | 3/3 | ENST00000247452.4 | NP_057333.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEC2 | ENST00000247452.4 | c.715A>G | p.Ile239Val | missense_variant | 3/3 | 1 | NM_016249.4 | ENSP00000354660.2 | ||
ENSG00000288098 | ENST00000664519.1 | n.300+7489T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000811 AC: 9AN: 110969Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33155
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183437Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67877
GnomAD4 exome AF: 0.0000155 AC: 17AN: 1098241Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 3AN XY: 363595
GnomAD4 genome AF: 0.0000811 AC: 9AN: 111020Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.715A>G (p.I239V) alteration is located in exon 3 (coding exon 1) of the MAGEC2 gene. This alteration results from a A to G substitution at nucleotide position 715, causing the isoleucine (I) at amino acid position 239 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at